SRS Medical has announced it has acquired a prostatic stent from AbbeyMoor Medical, according to a news release. The Spanner temporary prostatic stent is only FDA-cleared temporary stent for the male ...

ProVerum has closed an $80m Series B equity financing round, boosting commercialisation efforts for its ProVee system for benign prostatic hyperplasia (BPH). The funding round was led by MVM Partners, ...

Earlier this year, ProVerum presented data from a randomized, sham-controlled study at the annual meeting of the American Urological Association that met its primary ...

Wisconsin-based medtech Rivermark Medical has secured $20m in a Series D financing round – supporting the company's late-stage clinical activities being used for approval of its flagship device for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The privately-held 45-employee medical device maker had ...

DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it ...

In the last decade, several interventions have been approved for men with benign enlargement of the prostate gland. The ever-growing list of options ranges from steam treatment and permanent implants ...

The prostate is a small gland that plays an important role in male reproductive anatomy. Prostate problems can have a range of causes, including prostatitis, benign prostatic hyperplasia, and prostate ...